| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2'-5'-oligoadenylate synthetase 2 | 0.670 | 0.538 | 2.6E-21 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2017 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
3-hydroxyacyl-CoA dehydratase 1 | 0.539 | 0.846 | 1.3E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
5'-nucleotidase ecto | 0.436 | 0.885 | 2.3E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
6-pyruvoyltetrahydropterin synthase | 0.636 | 0.654 | 6.5E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
8-oxoguanine DNA glycosylase | 0.453 | 0.808 | 3.9E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
A-kinase anchoring protein 13 | 0.626 | 0.615 | 0.93 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
A-kinase anchoring protein 6 | 0.695 | 0.538 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1977 | 2001 | |||||||||
|
acetyl-CoA acyltransferase 1 | 0.729 | 0.462 | 3.6E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2018 | ||||||||
|
acid phosphatase 1 | 0.566 | 0.731 | 1.8E-08 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2019 | ||||||||
|
acidic nuclear phosphoprotein 32 family member B | 0.541 | 0.731 | 0.96 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
actin alpha 1, skeletal muscle | 0.540 | 0.769 | 1.1E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 1996 | 2018 | ||||||||
|
actin beta like 2 | 0.539 | 0.769 | 5.8E-16 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
actin gamma 2, smooth muscle | 0.505 | 0.808 | 7.1E-02 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
activated leukocyte cell adhesion molecule | 0.502 | 0.808 | 0.73 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
activating transcription factor 6 | 0.516 | 0.846 | 3.2E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2019 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2004 | 2007 |